Switch View
© Globe Newswire
05.09.2025
ISIN: US03969K1088
Arcutis Biotherapeutics Inc
ARQT
LISTED
NASDAQ
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
WESTLAKE VILLAGE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 35,500 restricted stock units of Arcutis’ common stock to four newly hired employees...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
CNC Deadline: CNC Investors with Losses in Excess of $100K Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (...
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Deadline Alert: LifeMD, Inc. (LFMD) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming October 27, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025, inclusive (the “Class Period”)....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
05.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Deadline Alert: Semler Scientific Inc. (SMLR) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming October 28, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Clas...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
05.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Deadline Soon: Centene Corporation (CNC) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming September 8, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “C...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release5 September 2025 WORLDWIDE HEALTHCARE TRUST PLC(the "Company") MARKET PURCHASE OF COMPANY'S OWN SHARES This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 9 July 2025 to make market purchases of the Company's own shares up to an aggregate maximum of 69,602,221....
Themefolio
Profiler
Peergroup
© EQS Newswire
05.09.2025
ISIN: CA68237C1059
Onco-Innovations Limited
ONCO
LISTED
CSE
Onco-Innovations ernennt Dr. John Mackey in das “Scientific and Clinical Advisory Board”
News Preview
Onco-Innovations Ltd. (ISIN: CA68237C1059 / WKN: A3EKSZ), Onco oder das Unternehmen, freut sich, die Ernennung von Dr. John Mackey, einem emeritierten Professor am Lehrstuhl für Onkologie der University of Alberta, in sein Scientific and Clinical Advisory Board bekannt zu geben. Mit seinen Fachkenntnissen wird er Onco dabei unterstützen, die transl......
Themefolio
Profiler
Peergroup
© Newsfile
05.09.2025
ISIN: CA6546521064
Nirvana Life Sciences Inc
NIRV
LISTED
CSE
CSE Bulletin: Suspensions - AION, CALI.X, LITS, NIRV
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 5 septembre/September 2025)Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Disclosure of notification received from Mawer
News Preview
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 5 September 2025 – 5:40 PM CET...
Themefolio
Profiler
Peergroup
© Newsfile
05.09.2025
ISIN: CA4576377002
InMed Pharmaceuticals Inc.
INM
LISTED
NASDAQ
InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced that the Company will be participating in the H....
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 4 September 2025 was 363.91p (cum income). ...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025
News Preview
Conference call scheduled for Monday, September 8, at 8:30 AM ET to discuss September 4 MolDX Contractor Advisory Committee (CAC) meeting
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
05.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Declares Quarterly Dividend
News Preview
NORTH CHICAGO, Ill., Sept. 5, 2025 The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share.
The cash dividend is payable November 14, 2025, to stockholders of record at the close of business on October 15, 2025.
Since the company's inception in 2013, AbbVie has increased its dividend by 31...
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2025-2026 Academic Year
News Preview
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced 25 recipients of Route 79, The Duchenne Scholarship Program, for the 2025-2026 academic year. Of the academic scholarships, 20 will be awarded to individuals living with Duchenne and five to siblings of individuals living with Duch...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
Levi & Korsinsky Notifies Shareholders of RxSight, Inc.(RXST) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to re...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Levi & Korsinsky Reminds Altimmune, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025 - ALT
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recov...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Lost Money on Neogen Corporation(NEOG)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Neogen Corporation ("Neogen Corporation" or the "Company") (NASDAQ: NEOG) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit s...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit.
CLASS DEFINITION: The law...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 19, 2025 to Discuss Your Rights - ANRO
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. ("Alto Neuroscience, Inc." or the "Company") (NYSE: ANRO) of a class action securities lawsuit.
CLASS DEFINITION: The l...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 14, 2025 in Unicycive Therapeutics, Inc. Lawsuit - UNCY
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit.
CLASS DEFIN...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
September 15, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CAPR
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit se...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Class Action Filed Against Centene Corporation (CNC) - September 8, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recov...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Levi & Korsinsky Notifies Biohaven Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - BHVN
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to reco...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Class Action Filed Against Nutex Health Inc. (NUTX) - October 21, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit see...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: SE0000736415
Orexo AB
ORX
LISTED
STO
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication
News Preview
A preclinical pharmacokinetic in-vivo study has been conducted in which the AmorphOX® technology was used to develop three powder-based intranasal formulations with semaglutide, which were compared with an oral and an injectable formulation.AmorphOX formulations demonstrated significantly higher plasma concentrations and higher bioavailability th...
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2025
ISIN: CA25253X2077
DiaMedica Therapeutics, Inc.
DMAC
LISTED
NASDAQ
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences
News Preview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction, and acute ischemic stroke, today announced that Rick Pauls, President and CEO, and Dave Wambeke, Chief Business Officer, will participate in two upcoming investor conferences in N...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: SE0000736415
Orexo AB
ORX
LISTED
STO
Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication
News Preview
A preclinical pharmacokinetic in-vivo study has been conducted in which the AmorphOX® technology was used to develop three powder-based intranasal formulations with semaglutide, which were compared with an oral and an injectable formulation.AmorphOX formulations demonstrated significantly higher plasma concentrations and higher bioavailability th...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CA89788C1041
Trulieve Cannabis Corp
TRUL
LISTED
CSE
Trulieve to Open New Dispensary in Bisbee, Arizona
News Preview
New Cochise County location will host grand opening celebration Friday, Sept. 12
TALLAHASSEE, Fla., Sept. 5, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new dispensary in Bisbee, Arizona....
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CA89788C1041
Trulieve Cannabis Corp
TRUL
LISTED
CSE
Trulieve to Open New Dispensary in Bisbee, Arizona
News Preview
New Cochise County location will host grand opening celebration Friday, Sept. 12
TALLAHASSEE, Fla., Sept. 5, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new dispensary in Bisbee, Arizona....
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia to collaborate with two leading academic medical centers to launch IMPACT-HTN - a US initiative to transform care for patients with difficult-to-control hypertension
News Preview
Multi-phase program to standardize treatment, generate real-world evidence, and explore AI-powered tools to improve outcomes for hypertension patientsALLSCHWIL, Switzerland and RADNOR, Pa., Sept. 5, 2025 /PRNewswire/ -- Idorsia Ltd (SIX: IDIA) announces a first-of-its-kind initiative with the Stanford Hypertension Center and Duke Heart Center to...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CNE100006XS6
Jiangsu Hengrui Pharmaceuticals Co Ltd
1276
LISTED
HKSE
Hengrui Pharma and Braveheart Bio Enter Exclusive License Agreement for Cardiac Myosin Inhibitor HRS-1893
News Preview
Collaboration highlights Hengrui Pharma's successful use of the NewCo model to achieve another out-licensing dealAgreement grants Braveheart Bio exclusive global rights to develop, manufacture and commercialize HRS-1893 outside of Mainland China, the Hong Kong SAR, the Macao SAR and Taiwan RegionHRS-1893 currently in Phase 3 clinical trial in Chi...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CA6546521064
Nirvana Life Sciences Inc
NIRV
LISTED
CSE
Canadian Investment Regulatory Organization Trading Halt - NIRV
News Preview
VANCOUVER, BC, Sept. 5, 2025 /CNW/ - The following issues have been halted by CIRO:
Company: Nirvana Life Sciences Inc.
CSE Symbol: NIRV
All Issues: Yes
Reason: Cease Trade Order
Halt Time (ET): 7:35 AM
CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are imple...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CA00905T1021
Aion Therapeutic Inc.
AION
LISTED
CSE
Canadian Investment Regulatory Organization Trading Halt - AION
News Preview
VANCOUVER, BC, Sept. 5, 2025 /CNW/ - The following issues have been halted by CIRO:
Company: Aion Therapeutic Inc.
CSE Symbol: AION
All Issues: Yes
Reason: Cease Trade Order
Halt Time (ET): 7:35 AM
CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
New Curaleaf Branded Dispensary Opens in New Albany, Ohio, in Partnership with RC Retail 2
News Preview
New location in New Albany, Ohio Marks 155 Curaleaf Retail Locations Nationwide
STAMFORD, Conn., Sept. 5, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of a new Curaleaf-branded dispensary near New Albany,...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
New Curaleaf Branded Dispensary Opens in New Albany, Ohio, in Partnership with RC Retail 2
News Preview
New location in New Albany, Ohio Marks 155 Curaleaf Retail Locations Nationwide
STAMFORD, Conn., Sept. 5, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of a new Curaleaf-branded dispensary near New A...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US75901B1070
Regenxbio Inc
RGNX
LISTED
NASDAQ
REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE® Trial of RGX-121 for Treatment of MPS II
News Preview
12-month pivotal data further demonstrate the ability of one-time RGX-121 treatment to improve outcomes for patients with MPS II>80% reduction in CSF levels of HS D2S6, key biomarker of MPS II brain disease, sustained through 1 yearPivotal patients demonstrate continued skill acquisition or stability, stratified by baseline function, through 1...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US5526411021
MAIA Biotechnology Inc
MAIA
LISTED
XASE
MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer
News Preview
Poster details durability and efficacy of ateganosine (THIO) treatment in non-small cell lung cancer (NSCLC)...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US23283X2062
Cytosorbents Corp
CTSO
LISTED
NASDAQ
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
PRINCETON, N.J., Sept. 5, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that management will present and participate in one-on-one meetings with investors at the H.C. Wainwright 27th Ann...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US7574683014
Redhill Biopharma Ltd
RDHL
LISTED
NASDAQ
RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights
News Preview
Extensive strategic, financial and operational overhaul has reshaped and refocused our business; Strong progress on multiple fronts
Commercial and R&D Highlights:
Recruitment initiated in the Bayer-supported Phase 2 combination study of opaganib and darolutamide in advanced prostate cancer Positive U.S. Food and Drug Administration (FDA) feed...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: US4576693075
Insmed Inc
INSM
LISTED
NASDAQ
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
BRIDGEWATER, N.J., Sept. 5, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 115 new employees. The awards were granted unde...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US6031701013
Mineralys Therapeutics Inc
MLYS
LISTED
NASDAQ
Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need
News Preview
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~...
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2025
ISIN: IT0004147952
Newron Pharmaceuticals SpA
NWRN
LISTED
SIX
Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP)
News Preview
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announced that it will present three posters and give an oral presentation at the upcoming 17th World Congress of Biological Psychiatry...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US15117F3029
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September
News Preview
FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that Jarrod Longcor, chief operating officer at Cellectar Biosciences, will participate in panel discussio...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: FR0000031577
Virbac SA
VIRP
LISTED
EURONEXT
Virbac : Declaration of the number of shares and voting rights 08/2025
News Preview
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: FR0000031577
Virbac SA
VIRP
LISTED
EURONEXT
Virbac : Declaration of the number of shares and voting rights 07/2025
News Preview
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: CNE100003N76
Shanghai Henlius Biotech, Inc.
2696
LISTED
HKSE
FUTUONING Sets Sail Commercially with First Prescriptions Across China
News Preview
SHANGHAI, Sept. 5, 2025 /PRNewswire/ -- These days, the first prescriptions of FUTUONING (fovinaciclib citrate capsules) were issued by more than ten hospitals across China, including Fudan University Shanghai Cancer Center, Cancer Hospital of the Chinese Academy of Medical Sciences, The First Affiliated Hospital Zhejiang University School of Med...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US71902K1051
CERo Therapeutics Holdings, Inc.
CERO
LISTED
NASDAQ
CERo Therapeutics Receives FDA Fast Track Designation for CER-1236 in Acute Myeloid Leukemia (AML)
News Preview
Regulatory milestone adds to its existing Orphan Drug Designation, creating additional regulatory and financial advantages for the Company’s lead cancer immunotherapy program...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025
News Preview
– 17 abstracts accepted, including one oral presentation –...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US8776191061
Taysha Gene Therapies Inc
TSHA
LISTED
NASDAQ
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
DALLAS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on September 2, 2025, the Compensation...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US28531P1030
electroCore, Inc.
ECOR
LISTED
NASDAQ
electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board
News Preview
ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from the Board of Directors and that Thomas J. Errico, MD, has been elected to succeed Mr. Cuneo as Chairman of the Board, effective September 2, 2025. Mr...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US6951271005
Pacira Biosciences Inc
PCRX
LISTED
NASDAQ
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on September 3, 2025 to nine new employees under Pacira’s Amended and Restated 2014 Inducem...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US3179701012
Firefly Neuroscience, Inc.
AIFF
LISTED
NASDAQ
Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America
News Preview
KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced a new partnership with HealingMaps, the leading directo...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on September 2, 2025, the Compensation Committee of the Company’s Board of Directors (the “Compensa...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US45107K1025
iBio Inc
IBIO
LISTED
NASDAQ
iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
News Preview
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced its financial results for the fiscal year ended June 30, 2025, and provided a corporate update on its progress....
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2025
ISIN: INE935A01035
Glenmark Pharmaceuticals Ltd
GLENMARK
LISTED
BSE
Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer
News Preview
DCGI grants No Objection Certificate to commence enrollment in India
Clinical Trial Applications underway in Russia, Brazil, and Mexico
MUMBAI, India, Sept. 5, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd., a research-led, global pharmaceutical company, today announced the initiation of a multi-country (ex-China) Phase 3 Clinical Trial for E...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
News Preview
~ All patients in the first cohort achieved between 27- to 208-fold increases in α-Gal A activity relative to mean normal level ~...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: CA58490H1073
Medicenna Therapeutics Corp
MDNA
LISTED
TSX
Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Medicenna will present and participate in one-on-one meetings at the H.C. Wainwright 27th Annual Global Investment Conference in New York City....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US1569441009
CG Oncology, Inc.
CGON
LISTED
NASDAQ
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
News Preview
- Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment -- 90% of 12-month responders remained disease free at 24 Months -- Safety profile remains consistent -...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US29384C1080
Entrada Therapeutics Inc
TRDA
LISTED
NASDAQ
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
News Preview
Entrada Therapeutics announces the recipients of its third annual DREAMS Grant Program....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2025
ISIN: US68752L1008
OrthoPediatrics Corp
KIDS
LISTED
NASDAQ
OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.
News Preview
Advancing Care for Pediatric Trauma Patients Advancing Care for Pediatric Trauma Patients...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
